PT86919A - Method for using morpholine derivatives in medicine and agriculture and respective process of preparation - Google Patents

Method for using morpholine derivatives in medicine and agriculture and respective process of preparation

Info

Publication number
PT86919A
PT86919A PT86919A PT8691988A PT86919A PT 86919 A PT86919 A PT 86919A PT 86919 A PT86919 A PT 86919A PT 8691988 A PT8691988 A PT 8691988A PT 86919 A PT86919 A PT 86919A
Authority
PT
Portugal
Prior art keywords
agriculture
medicine
preparation
respective process
morpholine derivatives
Prior art date
Application number
PT86919A
Other languages
English (en)
Other versions
PT86919B (pt
Inventor
Jonathan Robert Sanders Arch
Norman Harold Rogers
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878705587A external-priority patent/GB8705587D0/en
Priority claimed from GB888803261A external-priority patent/GB8803261D0/en
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of PT86919A publication Critical patent/PT86919A/pt
Publication of PT86919B publication Critical patent/PT86919B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Fodder In General (AREA)
PT86919A 1987-03-10 1988-03-08 Metodo para a utilizacao de derivados de morfolina em medicina e agricultura e respectivo processo de preparacao PT86919B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878705587A GB8705587D0 (en) 1987-03-10 1987-03-10 Compounds
GB888803261A GB8803261D0 (en) 1988-02-12 1988-02-12 Compounds & treatment

Publications (2)

Publication Number Publication Date
PT86919A true PT86919A (pt) 1988-04-01
PT86919B PT86919B (pt) 1992-05-29

Family

ID=26291994

Family Applications (1)

Application Number Title Priority Date Filing Date
PT86919A PT86919B (pt) 1987-03-10 1988-03-08 Metodo para a utilizacao de derivados de morfolina em medicina e agricultura e respectivo processo de preparacao

Country Status (9)

Country Link
US (2) US4914202A (pt)
EP (1) EP0290122B1 (pt)
JP (1) JPS646262A (pt)
AU (2) AU598644B2 (pt)
DE (1) DE3876846T2 (pt)
DK (1) DK123788A (pt)
HU (1) HU199440B (pt)
NZ (1) NZ223812A (pt)
PT (1) PT86919B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5281623A (en) * 1990-08-27 1994-01-25 Eli Lilly And Company Method for treating inflammation
US6265402B1 (en) 1996-08-27 2001-07-24 Nikken Chemicals Co., Ltd. Use of 2-phenylmorpholin-5-one derivatives
EP1112073A4 (en) * 1998-08-12 2002-10-25 Smithkline Beecham Corp CALCILYTIC COMPOUNDS
WO2014108449A1 (en) 2013-01-08 2014-07-17 Atrogi Ab A screening method, a kit, a method of treatment and a compound for use in a method of treatment
AU2017358060B2 (en) * 2016-11-09 2023-05-04 Charles Sturt University Livestock supplement and use thereof
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201903832D0 (en) 2019-03-20 2019-05-01 Atrogi Ab New compounds and methods
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses
EP4651867A1 (en) 2023-01-20 2025-11-26 Atrogi AB Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting
GB202302225D0 (en) 2023-02-16 2023-04-05 Atrogi Ab New medical uses
GB202303229D0 (en) 2023-03-06 2023-04-19 Atrogi Ab New medical uses
GB202403169D0 (en) 2024-03-05 2024-04-17 Atrogi Ab New medical uses
WO2025238248A1 (en) 2024-05-17 2025-11-20 Atrogi Ab USE OF β2-ADRENERGIC RECEPTOR AGONISTS IN TREATING MUSCLE WASTING

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2832777A (en) * 1956-11-26 1958-04-29 Searle & Co 2-aminophenyl-3-methylmorpholines
US3192208A (en) * 1962-07-31 1965-06-29 Lilly Co Eli Novel substituted morpholines and piperazines and processes for their synthesis
US3256278A (en) * 1963-04-01 1966-06-14 Rexall Drug Chemical N-hydroxy ethyl-ortho acetyl and carbalkoxy amino phenyl-glyoxamides and process formaking 2-orthoamino phenyl-morpholines
US4404222A (en) * 1980-08-25 1983-09-13 American Cyanamid Company Phenylethanolamine derivatives and acid addition salts thereof for enhancing the growth rate of meat-producing animals and improving the efficiency of feed utilization thereby
DE3175580D1 (en) * 1980-08-25 1987-01-02 American Cyanamid Co Method for enhancing the growth rate of meat-producing animals and for improving the lean meat to fat ratio thereof
DE3476386D1 (de) * 1983-11-02 1989-03-02 Beecham Group Plc Morpholine derivatives
GB8412862D0 (en) * 1984-05-19 1984-06-27 Beecham Group Plc Compounds
GB8418657D0 (en) * 1984-07-21 1984-08-22 Beecham Group Plc Compounds
PT82120B (en) * 1985-03-01 1988-06-16 Beecham Group Plc Process for preparing veterinary formulations containing ethanolamine derivatives

Also Published As

Publication number Publication date
NZ223812A (en) 1991-11-26
AU6301990A (en) 1991-01-10
PT86919B (pt) 1992-05-29
EP0290122B1 (en) 1992-12-23
DK123788A (da) 1988-09-11
US4914202A (en) 1990-04-03
JPS646262A (en) 1989-01-10
DK123788D0 (da) 1988-03-08
HUT49594A (en) 1989-10-30
AU1279788A (en) 1988-09-08
DE3876846D1 (de) 1993-02-04
EP0290122A1 (en) 1988-11-09
DE3876846T2 (de) 1993-04-29
US5082840A (en) 1992-01-21
AU598644B2 (en) 1990-06-28
HU199440B (en) 1990-02-28

Similar Documents

Publication Publication Date Title
FI884966A7 (fi) 1-desoksinojirimysiinin ja 1-desoksimannonojirimysiinin N-substituoidut johdannaiset, menetelmä niiden valmistamiseki ja niiden käyttö lääkkeissä
DK141979A (da) Hidtil ukendte carbazolyl-(4)-oxy-propanolaminderivater fremgangsmaade til deres fremstilling og laegemidler indeholdende disse forbindeser
FI941245A7 (fi) Menetelmä 2'-deoksiguanosiinin asyylijohdannaisten valmistamiseksi
PT81310A (fr) Procede de preparation de derives de piperidine et de compositions pharmaceutiques les contenant
FI882354L (fi) Menetelmä ihmisinsuliinista ja sen johdannaisista koostuvien sekakiteiden valmistamiseksi
FI891122A7 (fi) N-syklopropyylianiliinit ja niiden käyttö menetelmässä 1-syklopropyylikinolonikarboksyylihappojen ja niiden johdannaisten valmistamiseksi
FI891123A7 (fi) Menetelmä 1-syklopropyylikinolonikarboksyylihappojen ja niiden johdannaisten valmistamiseksi
NZ223812A (en) Morpholine derivatives and their use in agriculture and medicine
FI885942L (fi) Propoksibentseenijohdannaisia ja menetelmä niiden valmistamiseksi
PT87243A (pt) Process for the preparation of aliphatic carboxamides and of pharmaceutical compounds containing them
FI885692A0 (fi) Karboksimetyylisulfoetyyliselluloosa ja menetelmä sen valmistamiseksi
FI885766A7 (fi) Syklisten aminohappojen uusia johdannaisia, menetelmä niiden valmistamiseksi, niitä sisältäviä aineita ja niiden käyttö
PT87024A (pt) Process for the preparation of propiolophenone derivatives and of pharmaceutical compositions containing the same
HUT46910A (en) Process for production of new /benzofurane-2-il/-imidasole derivatives and their salts and medical preparatives containing such substances
FI885154A7 (fi) Sialosyyliglyserolipidejä ja menetelmä niiden valmistamiseksi
PT86898A (pt) Process for preparing 23-oxo(keto) and 23-imino derivatives of mono- and diepoxy ll-f28249 compounds
DE69028520D1 (de) Arzneimittelzubereitung bei der behandlung von tonsillitis
FR2553411B1 (fr) Derives de 2-halogenophenyl-morpholine, procede de preparation et utilisation en therapeutique
PT72247A (fr) Procede de preparation de nouveaux derives de l'amino-1 propanol-2 et leur application en therapeutique
NO174150C (no) Fremgangsmåte for fremstilling av furo-(3,4-c)pyridin-derivater i ikke-racemisk form
FR2626880B1 (fr) Derives n-substitues de 2-amino-1-phenylpropanone, procede de preparation et utilisation en therapeutique
FR2603287B1 (fr) Procede de preparation de complexes de metalloproteines et nouveaux derives de ceux-ci
FI930320L (fi) Alkyyli-3-alkoksikarbonyyli-2-pyrrolidinylideenikarboksylaatteja ja menetelmä niiden valmistamiseksi
YU45462B (en) Process for preparing derivatives of l-aspartyl-l-phenylalanyn and substance thereof
ZA881990B (en) Dicyanoethylaryl derivatives and process for their preparation

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19911111

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19930531